Company: BDRX
Filing Date: 2025-09-26
Form Type: F-3
Source: 0001214659-25-014255
Chunk: 4

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-09-26
Form: F-3
Chunk 4
---
 |    1 |
| PRESENTATION OF FINANCIAL INFORMATION AND OTHER DATA |    2 |
| PROSPECTUS SUMMARY                                   |    4 |
| RISK FACTORS                                         |    7 |
| SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS    |    8 |
| CAPITALIZATION                                       |   10 |
| USE OF PROCEEDS                                      |   11 |
| PLAN OF DISTRIBUTION                                 |   12 |
| DESCRIPTION OF SHARE CAPITAL                         |   14 |
| DESCRIPTION OF WARRANTS                              |   57 |
| DESCRIPTION OF UNITS                                 |   59 |
| DESCRIPTION OF AMERICAN DEPOSITARY SHARES            |   38 |
| EXPENSES                                             |   60 |
| LEGAL MATTERS                                        |   61 |
| EXPERTS                                              |   61 |
| ENFORCEMENT OF JUDGMENTS                             |   61 |
| WHERE YOU CAN FIND MORE INFORMATION                  |   61 |
| INCORPORATION OF DOCUMENTS BY REFERENCE              |   62 |

<div align='center'>ABOUT THIS PROSPECTUS</div>

This prospectus is part of
a registration statement that we filed with the Securities and Exchange Commission, or SEC, utilizing a “shelf” registration
process. Under this shelf registration process, we may offer Ordinary Shares, including Depositary Shares representing our Ordinary Shares,
various series of debt securities or warrants, and rights to purchase any of such securities, either individually or in units, in one
or more offerings, with a total value of up to $100,000,000. This prospectus provides you with a general description of the securities
we may offer. Each time we offer a type or series of securities under this prospectus, we will provide a prospectus supplement that will
contain specific information about the terms of that offering.

This prospectus does not contain
all of the information included in the registration statement. For a more complete understanding of the offering of the securities, you
should refer to the registration statement, including its exhibits. The prospectus supplement may also add, update or change information
contained or incorporated by reference in this prospectus. However, no prospectus supplement will offer a security that is not registered
and described in this prospectus at the time of its effectiveness. This prospectus, together with the applicable prospectus supplements
and the documents incorporated by reference into this prospectus, includes all material information relating to the offering of securities
under this prospect